MIFH
VYGR icon

Migdal Insurance & Financial Holdings’s Voyager Therapeutics VYGR Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-125
Closed -$2K – 756
2019
Q1 		$2K Hold
125
– – ﹤0.01% 693
2018
Q4 		$1K Hold
125
– – ﹤0.01% 692
2018
Q3 		$2K Hold
125
– – ﹤0.01% 770
2018
Q2 		$2K Buy
+125
New +$2.47K ﹤0.01% 738

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Migdal Insurance & Financial Holdings's VYGR Position: Q2 2019 in Review

Migdal Insurance & Financial Holdings sold out of Voyager Therapeutics (VYGR) in Q2 2019, closing a stake of 125 shares — an estimated $2K sold.

Migdal Insurance & Financial Holdings first reported a position in VYGR in Q2 2018 and held it in 4 quarters. The position peaked at $2K in Q1 2019. 125 funds tracked by Wall St. Rank hold VYGR as of Q2 2019.

  • Migdal Insurance & Financial Holdings reported no remaining Voyager Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 125 Voyager Therapeutics shares in Q2 2019, an estimated $2K.
  • Migdal Insurance & Financial Holdings first reported a position in Voyager Therapeutics in Q2 2018 and held it in 4 quarters.
  • Migdal Insurance & Financial Holdings's Voyager Therapeutics position peaked at $2K in Q1 2019.
  • 125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2019.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2019, filed 8 Aug 2019.